Wang Wei, Sun Tao, Meng Yingtao, Xu Min, Zhang Yingjie, Shao Qian, Song Yuanfang, Li Jianbin
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Department of Medical Physics, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Front Oncol. 2022 Mar 2;12:839831. doi: 10.3389/fonc.2022.839831. eCollection 2022.
The low rate of internal mammary node (IMN) recurrence was attributed to systemic therapy and internal mammary chain (IMC) coverage by the tangential fields of irradiation. This study aimed to evaluate the incidental irradiation dose to the IMC in breast cancer patients after surgery and to estimate the clinical predictive parameters affecting the magnitude of the IMC.
A total of 138 patients treated with postmastectomy radiotherapy and 210 patients undergoing radiotherapy after breast-conserving surgery (BCS) in our hospital were retrospectively analyzed. The mean dose (Dmean) to the IMC and the first to third intercostal spaces of IMC levels (ICS1-3) were evaluated. We evaluated the IMC coverage according to the type of surgery and whether the ipsilateral supraclavicular fossa (SCF) was included in the irradiation field.
The incidental radiation dose to the IMC was 29.69 Gy, and the dose delivered to the IMC, ICS1, and ICS2 showed a greater coverage in the modified radical mastectomy (MRM) group when compared with the BCS group (32.85 vs. 27.1 Gy, 26.6 vs. 12.5 Gy, 34.63 vs. 30.42 Gy). The dose delivered to ICS3 showed no difference between the MRM and BCS groups (37.41 vs. 36.24 Gy). Furthermore, 131 patients (37.64%) received radiotherapy to the chest wall and ipsilateral SCF. In the univariate analysis, both surgery type and SCF irradiation were parameters affecting the Dmean of incidental radiation to the IMC ( = -0.179, = 0.001; = -0.175, = 0.001). In the multivariate analysis, surgery type was the only correlative factor that affected incidental radiation dose to the IMC ( = -3.534, = 0.000).
The real influencing factor of incidental dose to the IMC was the surgery form rather than the accession of SCF irradiation.
内乳淋巴结(IMN)复发率低归因于全身治疗及切线野照射对内乳链(IMC)的覆盖。本研究旨在评估乳腺癌患者术后IMC的偶然照射剂量,并估算影响IMC剂量大小的临床预测参数。
回顾性分析我院138例行乳房切除术后放疗的患者及210例行保乳手术(BCS)后接受放疗的患者。评估IMC的平均剂量(Dmean)及IMC水平(ICS1 - 3)的第一至第三肋间间隙的剂量。根据手术类型及同侧锁骨上窝(SCF)是否包含在照射野内评估IMC覆盖情况。
IMC的偶然辐射剂量为29.69 Gy,与BCS组相比,改良根治术(MRM)组中IMC、ICS1和ICS2的照射剂量覆盖范围更大(32.85对27.1 Gy,26.6对12.5 Gy,34.63对30.42 Gy)。MRM组和BCS组中ICS3的照射剂量无差异(37.41对36.24 Gy)。此外,131例患者(37.64%)接受了胸壁及同侧SCF放疗。单因素分析中,手术类型和SCF照射均为影响IMC偶然辐射Dmean的参数(=-0.179,=0.001;=-0.175,=0.001)。多因素分析中,手术类型是影响IMC偶然辐射剂量的唯一相关因素(=-3.534,=0.000)。
IMC偶然剂量的真正影响因素是手术方式而非SCF照射的加入。